Garrison Bradford & Associates Inc / TMO
Garrison Bradford & Associates Inc’s Thermo Fisher Scientific Inc Position
Does Garrison Bradford & Associates Inc own Thermo Fisher Scientific Inc (TMO)? Yes — 7.5K shares worth $4M (+4.14% of its 13F portfolio) as of Q1 2026, down from 9.6K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
7.5K
% of Portfolio
+4.14%
Quarters Held
29
currently held
Position History TMO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 7.5K | $4M | +4.14% |
| Q4 2025 | 9.6K | $6M | +6.04% |
| Q3 2025 | 10.1K | $5M | +5.25% |
| Q2 2025 | 10.4K | $4M | +4.65% |
| Q1 2025 | 10.4K | $5M | +5.67% |
| Q4 2024 | 10.4K | $5M | +5.64% |
| Q3 2024 | 10.4K | $6M | +6.35% |
| Q2 2024 | 10.9K | $6M | +6.19% |
| Q1 2024 | 11.7K | $7M | +7.00% |
| Q4 2023 | 11.8K | $6M | +6.90% |
| Q3 2023 | 11.9K | $6M | +7.09% |
| Q2 2023 | 11.9K | $6M | +7.48% |
| Q1 2023 | 11.9K | $7M | +8.47% |
| Q4 2022 | 11.9K | $7M | +7.93% |
| Q3 2022 | 12.2K | $6M | +7.54% |
| Q2 2022 | 12.4K | $7M | +7.67% |
| Q1 2022 | 12.4K | $7M | +7.12% |
| Q4 2021 | 12.7K | $8M | +7.61% |
| Q3 2021 | 12.8K | $7M | +7.42% |
| Q2 2021 | 12.8K | $6M | +6.70% |
| Q1 2021 | 12.8K | $6M | +6.50% |
| Q4 2020 | 12.8K | $6M | +7.25% |
| Q3 2020 | 13.4K | $6M | +8.34% |
| Q2 2020 | 13.4K | $5M | +7.05% |
| Q1 2020 | 13.4K | $4M | +6.50% |
| Q4 2019 | 13.7K | $4M | +5.58% |
| Q3 2019 | 13.8K | $4M | +5.48% |
| Q2 2019 | 15.3K | $4M | +5.26% |
| Q1 2019 | 18.9K | $5M | +4.40% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Garrison Bradford & Associates Inc’s full portfolio or all institutional holders of TMO.